[1]Pigrau-Serrallach C, Rodríguez-Pardo D. Bone and joint tuberculosis. Eur Spine J, 2013: 22 Suppl 4:556-566.[2]秦世炳,宋言峥,董伟杰. 骨关节结核临床诊断与治疗进展及其规范化专题研讨会纪要. 中国防痨杂志,2013,35(1): 81-84.[3]Abbas A, Rizvi SR, Mahesri M, et al. Conservative management of spinal tuberculosis: initial series from pakistan. Asian spine J, 2013, 7(2): 73-80.[4]Bakhsh A. Medical management of spinal tuberculosis: an experience from Pakistan. Spine (Phila Pa 1976), 2010, 35(16):E787-791.[5]许建中. 脊柱结核的治疗方案存在仁智之争.中华骨科杂志, 2011,31(4): 394-399.[6]Bhojraj S,Nene A.Lumbar and lumbosacal tuberculous spondylodiscitis in adults:redefining indications for surgery.J Bone Joint Surg Br,2002,84(4):530-534.[7]谢燕萍.喹诺酮类药物研究进展. 临床合理用药,2012,5(1A):143-146.[8]Bhusal Y, Shiohira CM, Yamane N. Determination of in vitro synergy when three antimicrobial agents are combined against Mycobacterium tuberculosis. Int J Antimicrob Agents, 2005, 26(4): 292-297.[9]崔旭,马远征,李大伟,等. β-磷酸三钙/聚乳酸-聚羟基乙酸/异烟肼/左氧氟沙星缓释材料的成骨检测. 中国组织工程研究, 2013,17(3): 381-386.[10]王庆枫,戈启萍,初乃惠,等.左氧氟沙星的血药浓度指导肺结核患者剂量选择的临床观察.中国临床医生,2013,41(3):49-50. |